CTSO
Cytosorbents Corp
$0.37
-0.02 (-5.12%)
At close · Jul 16
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These cash and restricted cash balances considered with our historical and expected future cash used in operations, notwithstanding our Strategic Workforce and Cost Reduction Plan and the impact of the Amended Loan and Security Agreement, raises substantial doubt about the Company's ability to continue as a going concern within twelve months after the date that the accompanying condensed consolidated financial statements are issued.”View the 10-Q filed May 13, 2026
Market Cap
$22.61M
Shares
62,794,748
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Phillip Chan | CEO | $808,431 |
| Vincent Capponi | COO | $714,372 |
| Efthymios Deliargyris | Chief Medical Officer | $663,455 |
| Peter Mariani | CFO | $659,872 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Phillip Chan | CEO | $899,695 |
| Vincent Capponi | COO | $852,037 |
| Efthymios Deliargyris | Chief Medical Officer | $813,442 |
| Peter Mariani | CFO | $584,765 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Phillip Chan | CEO | $1,790,596 |
| Vincent Capponi | COO | $1,486,221 |
| Kathleen Bloch | CFO | $1,248,680 |
| Efthymios Deliargyris | Chief Medical Officer | $1,194,718 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Phillip Chan | CEO | $1,388,190 |
| Vincent Capponi | COO | $1,178,697 |
| Kathleen Bloch | CFO | $970,871 |
| Efthymios Deliargyris | Chief Medical Officer | $827,218 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Phillip Chan | CEO | $1,404,376 |
| Vincent Capponi | COO | $1,169,600 |
| Kathleen Bloch | CFO | $999,847 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Phillip Chan | CEO | $1,247,295 |
| Vincent Capponi | COO | $1,079,620 |
| Kathleen Bloch | CFO | $953,583 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Phillip Chan | CEO | $827,597 |
| Vincent Capponi | COO | $713,438 |
| Kathleen Bloch | CFO | $626,614 |